| Factor Information | |
|---|---|
| Data ID | 755 |
| Factor | NYHA class |
| Description | N/A |
| Biomarker | NA |
| Classification | A6 (clinical factor - other) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To access the predictor of adverse cardiac events |
| p Value | <0.001 |
| Conclusion | Death due to progressive heart failure or the occurrence of overt heart failure was best predicted by NYHA class. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 481 |
| CHD Type | isolated CHD |
| CHD Subtype | CRHD/ccTGA/D-TGA/SV/EIS/C-CHD |
| Reference | |
|---|---|
| PMID | 28886170 |
| Year | 2017 |
| Title | Homoarginine-A prognostic indicator in adolescents and adults with complex congenital heart disease? |
| Sample | ||
|---|---|---|
| Population | adolescent and adult | |
| Source | data | |
| Region | Germany | |
| Method | ROC curve analysis | |
| Race | European | |
| Disease History | N/A | |
| Treatment History | cardiac operation | |
| Group | died & overt heart failure(Treatment) | Other(Control) |
| Number | 19(4 died+15overt heart failure) | 124 |
| Age | 27.5±12.0 years | 27.5±12.0 years |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | N/A | N/A |
